Pentalpha Engaged on 10 CMBS Transactions in 2017

We represented Pentalpha Surveillance LLC (Pentalpha) in its capacity as operating advisor and/or asset representations reviewer in seven SEC-registered commercial mortgage-backed securities transactions that involved collateral valued in excess of $5.5 billion in the first quarter of 2017, as well as three large-loan 144A deals that involved collateral valued in excess of $1.6 billion. Pentalpha is often retained by CMBS issuers such as Wells Fargo, J.P. Morgan and Goldman Sachs to provide third-party independent oversight of loan securitization trusts’ ongoing operations.

Pentalpha provides a suite of highly specialized products and services to the pace-setters of the international credit markets and structured finance industries. As of May 31, 2017, Pentalpha Surveillance has acted as operating advisor or trust advisor in approximately 105 commercial mortgage-backed securitizations with an aggregate initial unpaid principal balance of approximately $111 billion since October 2010, and as asset representations reviewer in 22 commercial mortgage-backed securitizations with an aggregate initial unpaid principal balance of approximately $21 billion.

You Also May Be Interested In:

  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company